miércoles, 8 de enero de 2014

Today’s articles on Investing Ideas

Top Ideas

Bill Barrett: The Niobrara And Uinta Upside
by Richard Zeits

Editor's notes: Energy expert Zeits says BBG's assets in two younger oil plays are set to propel the stock higher once the market understands their favorable economics. 40%+ upside.

TechTarget: New Big Data Analytics Product And Operating Leverage Should Drive Double Digit Sales And Earnings Growth
by Ben Axler

Editor's notes: Online content that is set to make investors content. According to buysider Ben Axler, conservative estimates and modest stock coverage leave TTGT with more than 30% upside potential.

Trouble Ahead For TAL
by BrooklynShorty

Editor's notes: The expiry of favorable leases, and a concern for short-term reporting advantages suggest things aren't as good as they seem at TAL International. Shares could fall by two-thirds.

TRW Automotive: Built For Outperformance In 2014 And Beyond
by Trading the Spread

Editor's notes: This high-flying stock remains undervalued relative to peers and growth opportunities. Strong Balance Sheet management reduces the downside, while shares of TRW could appreciate another 35%.

Agilysys: On The Cusp Of Major Earnings Growth
by Shaun Currie, CFA

Editor's notes: A very attractive balance sheet, high composition of recurring revenue, and market potential make AGYS very appealing at these levels. Look for 30% appreciation.

InterXion Holding NV: Undervalued, Catalyst-Heavy And A Secular Growth Story All In One
by Alpha Gen Capital

Editor's notes: The cloud-computing space is far more attractive in Europe than North America, and InterXion has a foothold in this market. Amid choppy trading, INXN is some 50% undervalued.

Stocks Moving From Top Ideas

On December 23, Dennis Beaudet argued that concerns about auto parts maker Martinrea International simply didn't warrant the recent decline in share price, a decline that put the stock into deep value territory. Shares are +11.7% to date. Read article »

Dane Bowler wrote on May 20 that commercial mREIT Northstar Realty Finance offered a sustainable and growing 8% yield, along with the opportunity for large potential capital appreciation. Despite weakness across the sector, the stock is now +44.9% since his call. Read article »

Long Ideas

3 Reasons Why You Should Buy J.C. Penney by Paul Boland

Kellogg Vs. General Mills: The Future Of The Packaged Food Industry by Shawn Arshad

As Production Resumes At Its East Dubuque Facility, Here's Why I'm Long Rentech Partners by Heather Ingrassia

Here's What You Need To Know About Micron Technology by Leigh Drogen

Neostem Could Rally On Phase II Results by Brian L. Wilson

Intel's 3DFET SOCs Aim To Capture Top Of The Mobile Market by Arnold Frisch

Can Alibaba Save Yahoo's Sinking Ship? by Blackstone Equity Research

Micron: Strong Buy On Q1 2014 Results by Achilles Research

Microsoft: Buy And Be Glad Mulally Isn't Taking Over by Seeking Profits

Time To Play Starbucks? by Nizar Tarhuni

How Much Should Liberty Offer For Sirius XM? by Spencer Osborne

As Expected, Sirius Reports 2013 Subs And 2014 Guidance by Crunching Numbers

Michelin To Benefit From The Improving Global Automotive Market Outlook by Junius

Ocean Bio-Chem Is Undervalued, Overlooked And On The Verge Of Disrupting Multiple Markets by John Leonard

Intel At CES 2014: Lots To Like But No Cake Today by Michael Blair

Berkshire Hathaway Streak To Most Likely End by Sean Weston

Prognosticating 2014: Athersys Shares Will Continue To Climb by U.S. Biotech Investor

Nvidia: Will 2014 Be An Inflection Point? by Marsha Robe

Orexigen Receives Good News From FDA by Spencer Osborne

ConocoPhillips: In Search Of More Hydrocarbons And Cash Flow by Marsha Robe

Intel: Don't Be Fooled, Mobile Is Important by Ashraf Eassa

Texas Roadhouse: Another 50% Potential In 2014 As Food Costs Rise Less by The Oxen Group

BP Returns To Growth by Gabe Ortt

DryShips Is Consolidating Large Gains by Giovanni DiMauro

Sorrento Therapeutics: Has The Potential To Become Next Abraxis by Grant Zeng

3 Reasons Why You Should Buy Baidu by Pawel Perz

Intel: A 'Better-Than-Feared' Investment by Bottom Up Investing

Why DineEquity Is Not A Bubble About To Burst by Marshall Hargrave

Is Chesapeake A Good Long-Term Investment Opportunity? by Investing Insight

AMD - Downside Capped, Play The Upside by Sneha Shah

Should You Buy Ford After The Sell-Off? by Jacob Steinberg

Where Does Dolan Go From Here? by Colin King

Axiall Stuck In A Commodity Tug Of War by Stephen Simpson, CFA

Real Goods Solar, Inc. Has The Goods by The Focused Stock Trader

Who Is The CEO To Bet On: Greg Ebel Or Rich Kinder? by Bram de Haas

J.C. Penney Stock Weak/Bonds Strong: What That Tells Us About December Comps, And Valuation Update by Dante's Investing Ideas

Disney: Is Infinity Leading The Way For A New Business Model? by Lutz Muller

Kraft Food: Current Segmentation Appears Fruitful by Balanced Investing

Will Ugly Headlines Spur A JetBlue Buying Opportunity? by Quoth the Raven

Will Abbott Perform Better In 2014? by Apex Financial Consultants

The Market Already Looking To A Stronger 2014 For Steel Dynamics by Stephen Simpson, CFA

Internet Patent Corporation: No Downside Risk, Let The Upside Take Care Of Itself by Matthew Dow

Is Iron Road's Central Eyre Iron Ore Project Attractive Now? by The Investment Doctor

Netflix Still Has Room To Grow by I Know First Research

Why This Company Should Be A Case Study In Business Schools by Profit Confidential

Identive Group: Entering 2014 Leaner And Meaner (Update) by Micro-Cap Gem Finder

Brown Shoe: Good Execution In 2013, Opportunities In 2014 And Beyond by Pendulum

Plug Power: Hold On, The Sky Is The Limit by Charles Fox

Timberland: Sometimes You Can't See The Forest For The Trees by Stephen Rosenman

Cold Weather, Low Costs, And Higher Gas Helping Cloud Peak Energy by Stephen Simpson, CFA

Growlife: Missed The Big Move? Catch The Second Big Move by Jason Bond

BioPharma Catalyst And Investment Pick In Focus: Progenics by StockMatusow

Progenics Likely To Announce Positive Prostate Cancer Data In January by Gotham City Capital

Short Ideas

Intel Needs To Deliver Next Week by Bill Maurer

Sell Ranbaxy - Recent Run Up Provides An Opportunity For Investors To Exit by Pharma Intelligence

Why The Netflix Slide Could Turn Into An Avalanche by Markos Kaminis

Portfolio Manager Sees Many Troubling Signs With NQ Mobile by Goldbaum Research

Court Documents Show Suntech Power Shares Almost Worthless by Bledsoe Research Group

Diamond Resorts Unlocking Provides Shorting Opportunity by Don Dion

Organovo: Modest Expectations For The Liver Tox Assay by Douglas W. House

Nuverra Environmental: Lowering 2014 Target Price To $0 by MBAvalueinvestor

Foreshadowing RadioShack's Death? by Quoth the Raven

Deere Is No Longer 'Dear' To Investors... by Balanced Investing

OFG Bancorp: Not A Bank In Cyprus But It's Close by Paulo Santos

Trouble Is Brewing At Farmer Brothers Coffee by Richard Pearson

Memo To Snapchat: Take The Facebook Money And Run by Kofi Bofah

Quick Picks & Lists

Stock Watch Wednesday, January 8, 2013: Beware Of Overconfidence by VFC's Stock House

Top 5 Silver Stocks For 2014 by Steve Nicastro

4 Growth And Income Stocks To Buy After A Correction by Marc Courtenay

Pandora's Growth Rate Continues To Decline by Andrei Volgin

Why Target Must Accept Bitcoin Like Zynga And Before Walmart Or Amazon by Trace Mayer

Zacks' Bear Of The Day: Darden Restaurants by Zacks Investment Research

Zacks' Bull Of The Day: Amazon by Zacks Investment Research

Reluctantly Picking Turnaround Stock Favorites For 2014 by George Putnam

Why Dillard's Is One Of The Top Department Store Stocks To Buy by Stan Stafford

The Life Insurance Industry Is Ripe For The Picking: Revisited by Todd Denning

2 Cash Rich $2 Stocks For The New Year by Bret Jensen

3 Ways To Play The Shale Oil Boom by Dave Dierking

Jamba Juice - Weather And Competition Concerns Outweigh Menu Innovation by The Value Investor

An Introduction To Neurotrophic Factors As Treatment For Neurodegenerative Diseases by Tal Ben-Ami

Phillips 66 - Creative Deal Shows Buffett Is Getting Cautious by The Value Investor

Dividends Or Buybacks? 2013 Review & 2014 Picks by Brad Kenagy

Johnson & Johnson And Medivation: A Prostate Cancer Marketshare by John Eastman

Can Healthcare Stocks Continue To Thrive? I Think Not by Adam Alvarez

Boeing Continues To Roll In 2014 by Bret Jensen

Why BlackBerry Is Still On The List, As 2013 Buy/Sell Calls Are Reviewed by Chris Lau

Top 20 TSX Short Positions Dec. 31 by Chris Damas

Cramer's Picks

Cramer's Lightning Round - 2 Ways The Times Can Win (1/7/14) by SA Editor Miriam Metzinger

Cramer's Mad Money - My New Year's Resolution For Investing (1/7/14) by SA Editor Miriam Metzinger

Fund Holdings

Private Equity In China: It's Changing, But From What? Into What? by Peter Fuhrman

Insider Ownership

Automatic Data Processing: 10 Different Insiders Have Sold Shares This Year by Markus Aarnio

Illumina: 4 Different Insiders Have Sold Shares During The Last 30 Days by Markus Aarnio

IPO Analysis

2013: The IPO Year In Review by Tim Keating


Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

No hay comentarios:

Publicar un comentario